Chemistry:Camlipixant
From HandWiki
Camlipixant is an investigational new drug that is being evaluated for the treatment of chronic cough.[1] It is a P2X3 receptor antagonist.[2]
See also
References
- ↑ "Camlipixant - BELLUS Health". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800052547.
- ↑ "BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration". Pulmonary Pharmacology & Therapeutics 56: 56–62. June 2019. doi:10.1016/j.pupt.2019.03.007. PMID 30902655.
 |  |
